UCSF Helen Diller Family Comprehensive Cancer Center

Photo of Robert S. Warren, MD  Robert S. Warren, MD

Professor, Department of Surgery, UCSF

Contact

(415) 353-9888 (appts)
(415) 885-3802 (fax)

Box 1932, UCSF; San Francisco, CA 94143-1932

Additional websites:
    Physician Referral Directory

Education

Cornell University, Ithaca, NY, 1966-1967, English
Lawrence University, Appleton, Wisconsin, 1967-1968, Biology
Univ. of Minnesota, Minneapolis, MN, B.A., 1969-1971, Physiology
Grad. School, Univ. of Minnesota, Minneapolis, MN, 1971-1975, Cell Biology
Med. School, Univ. of Minnesota, Minneapolis, MN, M.D., 1976-1980, Medicine

Professional Experience

  • 1980-1983, 1986-1988
    Surgery Internship and Residency, University of Minnesota
  • 1983-1986
    Fellowship, Memorial Sloan-Kettering Cancer Center; NY, NY
  • 1984-1985
    Associate Physician, Rockefeller University; NY, NY
  • 1988-1994
    Assistant Professor, Department of Surgery, Univ. of Calif., San Francisco
  • 1994-present
    Associate Professor, Department of Surgery, Univ. of Calif., San Francisco
  • 1995-2011
    Chief, Surgical Oncology Program, Department of Surgery, Univ. of Calif., San Francisco
  • 2000-present
    Professor, Department of Surgery, Univ. of Calif., San Francisco

Honors & Awards

  • 1971
    BA magna cum laude
  • 1980
    Alpha Omega Alpha Honorary Medical Society

Selected Publications

  • Wang DF, Lehman RE, Donner DB, Matli MR, Warren RS, and Welton ML: Expression and endocytosis of VEGF in human vascular endothelial cells. Am J Physiol Gastrointest Liver Physiol 282:G1088-96, 2002.
  • Kinkel K, Lu Y, Both M, Warren RS, and Ruedi F: Toeni detectionof hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): A meta-analysis. Radiology 224:748, 2002.
  • Lipshutz GS, Brennan TV, Warren RS: Thorotrast-induced liver neoplasia. Journal of American College of Surgeons 11:571-88, 2002.
  • Reid T, Warren RS, Kirn D: Intravascular adenoviral agents in cancer patients: Lessons from clinical trials. Cancer Gene Therapy 9:979-86, 2002.
  • Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garcia P, Fuller J, Chan V, Rohan M, Randazzo F, Reinhard C, Gundel R, Escobedo J, Warren RS, AukermanS , Taylor RN and Fantl WJ: Beta-Catenin Regulates Vascular Endothelial Growth Factor (VEGF-A) Expression in Colon Cancer. Cancer Research, 63:3145-53, 2003.
  • Lvoff N, Breiman RS, Coakley FV, Lu Y, Warren RS: Distinguishing features of self-limiting adult small-bowel intussusception identified at CT. Radiology 227:68-72, 2003.
  • Vessey DA, Lau E, Kelley M, Warren RS: Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid: CoA ligase from human liver mitochondria. Journal of Biochemical and Molecular Toxicology 17:1-6, 2003.
  • Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 134:1057-63, 2003.
  • Vessey DA, Kelley M, Warren RS: Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver. Journal of Biochemical and Molecular Toxicology 18:100-106, 2004
  • Ruan DT, Warren RS: Palliative techniques for hepatic cancer. Surgical Oncol Clin N Am: 13:505-16, 2004.
  • Arvold ND, Guha N, Wang DF, Matli MR, Deen DF, Haas-Kogan DA, and Warren RS: Hypoxia-induced radioresistance is independent of hypoxia-induced factor-1 in vitro. Int J Radiat Oncol Biol Phys.: 62:207-12. 2005.
  • Ruan DT, and Warren RS: Liver-directed Therapies in Colorectal Cancer. Seminars in Oncology 32: 85-94, 2005.
  • Ruan DT, Warren RS: Liver directed therapies in colorectal cancer. Clinical Cancer Research 11: 1791-1797, 2005.
  • Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM: Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer. Clin Cancer Res., 11:1791-7, 2005.
  • Tempero MA, Behrman S, Ben-Josef E, Benson AB 3rd, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW 2nd, Melvin WS, Muscarella P 2nd, Sasson AR, Shibata S, Shrieve DC, Talamonti MS, Tyler DS, Vickers SM, Warren RS, Willett C, and Wolff RA: Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 3:598-626, 2005.
  • Korn WM, Macal M, Christian C, Lacher M, McMillan A, Rauen KA, Warren RS, and Ferrell L: Expression of The Coxsackievirus- and Adenovirus Receptor in Gastrointestinal Cancer Correlates with Tumor Differentiation. Cancer Gene Therapy 13:792-7, 2006.
  • Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, and Warren RS: Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Therapy, 13:169-81, 2006.
  • Kemeny NE, Niedzwiecki d, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE 2nd, Zhang C, Mayer RJ: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol, 24:1395-403, 2006.
  • Rajpal S, Warren RS, Alexander M, Yeh BM, Grenert JP, Hintzen S, Ljung BM, and Bergsland EK: Pancreoblastoma in an adult: case report and review of the literature. J Gastrointest Surg, 10:829-36, 2006.

Updated: December 20, 2011